chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itchy around the injection site; red circle around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy around the injection site) and VACCINATION SITE ERYTHEMA (red circle around the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy around the injection site) and VACCINATION SITE ERYTHEMA (red circle around the injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy around the injection site) and VACCINATION SITE ERYTHEMA (red circle around the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: No specific follow-up information recorded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and CHILLS (chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). At the time of the report, PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: swollen arm; warm to touch at the injection site; hardness at the injection site; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), VACCINATION SITE WARMTH (warm to touch at the injection site), VACCINATION SITE INDURATION (hardness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm), VACCINATION SITE WARMTH (warm to touch at the injection site), VACCINATION SITE INDURATION (hardness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site). At the time of the report, PERIPHERAL SWELLING (swollen arm), VACCINATION SITE WARMTH (warm to touch at the injection site), VACCINATION SITE INDURATION (hardness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: My left wrist is hurting, and it gives out; On my right side, I am having really sharp pains; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (My left wrist is hurting, and it gives out) and PAIN (On my right side, I am having really sharp pains) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included High cholesterol (Patient was taking cholesterol medication) since an unknown date. Concomitant products included VITAMIN E NOS, FISH OIL, GARLIC [ALLIUM SATIVUM] and METOPROLOL TARTRATE for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ARTHRALGIA (My left wrist is hurting, and it gives out) and PAIN (On my right side, I am having really sharp pains). At the time of the report, ARTHRALGIA (My left wrist is hurting, and it gives out) and PAIN (On my right side, I am having really sharp pains) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included unspecified cholesterol medication.  The patient did not receive any treatment medication  3-5 hours after the vaccine the symptoms started. Her left wrist is hurting, when she picks something up, it gives up and she drops whatever she is holding. It goes on and off. On her right side, she was having really sharp pains, every 30 min-1 hours.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Vaccination site pain, Vaccination site swelling
Clinical narrative: Swelling Injection Site; Sore Injection Site; Armpit is Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling Injection Site), VACCINATION SITE PAIN (Sore Injection Site) and AXILLARY PAIN (Armpit is Sore) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling Injection Site), VACCINATION SITE PAIN (Sore Injection Site) and AXILLARY PAIN (Armpit is Sore). At the time of the report, VACCINATION SITE SWELLING (Swelling Injection Site), VACCINATION SITE PAIN (Sore Injection Site) and AXILLARY PAIN (Armpit is Sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 28-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications reported.    Reporter did not allow further contact
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Vaccination site lymphadenopathy
Clinical narrative: swollen lymph nodes at the arm; Stopped menstrual cycle; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes at the arm) and AMENORRHOEA (Stopped menstrual cycle) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012C26A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes at the arm) and AMENORRHOEA (Stopped menstrual cycle). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes at the arm) was resolving and AMENORRHOEA (Stopped menstrual cycle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Vaccination site pruritus
Clinical narrative: Delayed itchy rash; Fever that went awat overnight; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Delayed itchy rash) and PYREXIA (Fever that went awat overnight) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PYREXIA (Fever that went awat overnight). On 28-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Delayed itchy rash). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Itchy, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Delayed itchy rash) had not resolved and PYREXIA (Fever that went awat overnight) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: not provided results not provided. She had a covid 19 test that came back a week earlier.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm is hurting a lot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is hurting a lot) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm is hurting a lot). At the time of the report, PAIN IN EXTREMITY (arm is hurting a lot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment medication was reported.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Vaccination site pain
Clinical narrative: Headache; Soreness at the injection site; Fatigue; A little nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), VACCINATION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue) and NAUSEA (A little nausea) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (Headache), VACCINATION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue) and NAUSEA (A little nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache), VACCINATION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue) and NAUSEA (A little nausea) had not resolved.            No concomitant medications were provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache) had resolved.            No treatment information was provided. No relevant concomitant medications reported.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: low-grade fever 99F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low-grade fever 99F) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PYREXIA (low-grade fever 99F). At the time of the report, PYREXIA (low-grade fever 99F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 99 (Borderline) 99 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: big red rash on the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (big red rash on the injection arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced RASH ERYTHEMATOUS (big red rash on the injection arm). At the time of the report, RASH ERYTHEMATOUS (big red rash on the injection arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Influenza, Oropharyngeal pain
Clinical narrative: cough; sore throat; Flu; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and INFLUENZA (Flu) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination.     Concomitant products included GABAPENTIN for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and INFLUENZA (Flu). At the time of the report, COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and INFLUENZA (Flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was High blood pressure med.  The treatment medication was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: body ache; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), CHILLS (chills) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN (body ache), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN (body ache), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported. No medical history was provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: slight sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (slight sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included IRON and VITAMINS NOS for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (slight sore arm). At the time of the report, PAIN IN EXTREMITY (slight sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.         No treatment medications were reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site pain, Limb discomfort, Malaise, Nasopharyngitis
Clinical narrative: arm was very sore; hard to lift; felt very unwell; lightheaded; was very cold; very minor soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (very minor soreness at the injection site), PAIN IN EXTREMITY (arm was very sore), LIMB DISCOMFORT (hard to lift), MALAISE (felt very unwell) and DIZZINESS (lightheaded) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (very minor soreness at the injection site). On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was very sore), LIMB DISCOMFORT (hard to lift), MALAISE (felt very unwell), DIZZINESS (lightheaded) and NASOPHARYNGITIS (was very cold). At the time of the report, INJECTION SITE PAIN (very minor soreness at the injection site), PAIN IN EXTREMITY (arm was very sore), LIMB DISCOMFORT (hard to lift), MALAISE (felt very unwell), DIZZINESS (lightheaded) and NASOPHARYNGITIS (was very cold) outcome was unknown.             Treatment reported include Ibuprofen Motrin 200mg 3 tabs.      This case was linked to MOD-2021-035895 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was very sore; hard to lift; felt very unwell; lightheaded; was very cold; very minor soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (very minor soreness at the injection site), PAIN IN EXTREMITY (arm was very sore), LIMB DISCOMFORT (hard to lift), MALAISE (felt very unwell) and DIZZINESS (lightheaded) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (very minor soreness at the injection site). On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was very sore), LIMB DISCOMFORT (hard to lift), MALAISE (felt very unwell), DIZZINESS (lightheaded) and NASOPHARYNGITIS (was very cold). At the time of the report, INJECTION SITE PAIN (very minor soreness at the injection site), PAIN IN EXTREMITY (arm was very sore), LIMB DISCOMFORT (hard to lift), MALAISE (felt very unwell), DIZZINESS (lightheaded) and NASOPHARYNGITIS (was very cold) outcome was unknown.             Treatment reported include Ibuprofen Motrin 200mg 3 tabs.      This case was linked to MOD-2021-035895 (Patient Link).
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Nausea
Clinical narrative: Soreness at the injection site; Fatigue; Headache; A little nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (A little nausea) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INJECTION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (A little nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (A little nausea) outcome was unknown. Not Provided          No relevant concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Cancer (Diagnosed for prostrate cancer 7 years ago and recently got the treatment as "took out small spot on vertebrate". Also reported to finish 5 radiation 2 weeks ago on 19-Feb-2021.).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included basic vitamin. The patient also took acupuncture. No treatment was reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site rash, Pain in extremity, Type IV hypersensitivity reaction
Clinical narrative: COVID-arm // 1st dose; soreness on arm // 1st dose; redness in the arm // 1st dose; Rash // 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (COVID-arm // 1st dose), PAIN IN EXTREMITY (soreness on arm // 1st dose), ERYTHEMA (redness in the arm // 1st dose) and INJECTION SITE RASH (Rash // 1st dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 011A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included INFLIXIMAB (REMICADE), AZATHIOPRINE (IMURAN [AZATHIOPRINE]), LISINOPRIL, FISH OIL (FISH OIL OMEGA 3), PANTOPRAZOLE and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (COVID-arm // 1st dose), PAIN IN EXTREMITY (soreness on arm // 1st dose), ERYTHEMA (redness in the arm // 1st dose) and INJECTION SITE RASH (Rash // 1st dose). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (COVID-arm // 1st dose), PAIN IN EXTREMITY (soreness on arm // 1st dose), ERYTHEMA (redness in the arm // 1st dose) and INJECTION SITE RASH (Rash // 1st dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No corrective treatment was provided.   This case was linked to MOD-2021-229309 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy
Clinical narrative: Lump under armpit (left arm injection site); Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and LYMPHADENOPATHY (Lump under armpit (left arm injection site)) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced FATIGUE (Fatigue). On 08-Mar-2021, the patient experienced LYMPHADENOPATHY (Lump under armpit (left arm injection site)). At the time of the report, FATIGUE (Fatigue) and LYMPHADENOPATHY (Lump under armpit (left arm injection site)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: bad reaction and went to ER; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (bad reaction and went to ER) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (bad reaction and went to ER). At the time of the report, ADVERSE REACTION (bad reaction and went to ER) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included IV. No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Non-Significant Follow up received and Contact details were updated.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: Administered 1ml of the Moderna Covid19 vaccine instead of just 0.5ml; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Administered 1ml of the Moderna Covid19 vaccine instead of just 0.5ml) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No historical condition reported).    On 06-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 06-Mar-2021, the patient experienced ACCIDENTAL OVERDOSE (Administered 1ml of the Moderna Covid19 vaccine instead of just 0.5ml). On 06-Mar-2021, ACCIDENTAL OVERDOSE (Administered 1ml of the Moderna Covid19 vaccine instead of just 0.5ml) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.; Sender's Comments:
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Vaccination site warmth; Vaccination site erythema; Vaccination site pruritus; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (Vaccination site pruritus) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (Vaccination site pruritus). At the time of the report, VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (Vaccination site pruritus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported. No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: High fever 101.1; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High fever 101.1) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (High fever 101.1). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (High fever 101.1) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 101.1 (Inconclusive) 101.1 F.         No relevant concomitant medications were reported. Action taken with mRNA-1273(Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: arm itchy; arm pink; arm hurt; warm around the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm hurt), VACCINATION SITE WARMTH (warm around the vaccination site), VACCINATION SITE PRURITUS (arm itchy) and VACCINATION SITE ERYTHEMA (arm pink) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm hurt) and VACCINATION SITE WARMTH (warm around the vaccination site). On 07-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (arm itchy) and VACCINATION SITE ERYTHEMA (arm pink). The patient was treated with ICHTHAMMOL (VASELINE ICHTYOLEE) for Itchy, at an unspecified dose and frequency. On 03-Mar-2021, VACCINATION SITE PAIN (arm hurt) had resolved. At the time of the report, VACCINATION SITE WARMTH (warm around the vaccination site), VACCINATION SITE PRURITUS (arm itchy) and VACCINATION SITE ERYTHEMA (arm pink) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Report joint pain after receiving the Moderna COVID-19 vaccination; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Report joint pain after receiving the Moderna COVID-19 vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Report joint pain after receiving the Moderna COVID-19 vaccination). At the time of the report, ARTHRALGIA (Report joint pain after receiving the Moderna COVID-19 vaccination) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-036059 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Urticaria
Clinical narrative: insomnia; hives on her back; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (insomnia) and URTICARIA (hives on her back) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced INSOMNIA (insomnia) and URTICARIA (hives on her back). On 24-Feb-2021, INSOMNIA (insomnia) and URTICARIA (hives on her back) had resolved.            Concomitant medications taken by the patient were not provided. Treatment activities for the events was reported as none.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain
Clinical narrative: pain all the way down to the hip; myalgia; pain all the way down to the ankle; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (myalgia), ARTHRALGIA (pain all the way down to the ankle) and PAIN (pain all the way down to the hip) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031120A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced MYALGIA (myalgia) and ARTHRALGIA (pain all the way down to the ankle). On 04-Mar-2021, the patient experienced PAIN (pain all the way down to the hip). On 04-Mar-2021, ARTHRALGIA (pain all the way down to the ankle) had resolved. At the time of the report, MYALGIA (myalgia) and PAIN (pain all the way down to the hip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Tylenol for unknown indication.  No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Condition aggravated, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: red; AE contact information not updated; red; Itchiness; Spreading to other areas; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of ERYTHEMA (red), PRURITUS (Itchiness), CONDITION AGGRAVATED (Spreading to other areas), the second episode of ERYTHEMA (red) and ERYTHEMA (better now) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced the first episode of ERYTHEMA (red), PRURITUS (Itchiness) and CONDITION AGGRAVATED (Spreading to other areas). On an unknown date, the patient experienced the second episode of ERYTHEMA (red), ERYTHEMA (better now) and ADVERSE EVENT (AE contact information not updated). At the time of the report, PRURITUS (Itchiness) and CONDITION AGGRAVATED (Spreading to other areas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: NNI On 03-May-2021: contact information updated
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased
Clinical narrative: couldn't lift his arm; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (couldn't lift his arm) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (couldn't lift his arm). At the time of the report, MOBILITY DECREASED (couldn't lift his arm) outcome was unknown.            Patient has lupus. Treatment information not provided. List of concomitant medication were not given.
Age: 75.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Vaccination site swelling
Clinical narrative: arm was swollen; slight chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE SWELLING (arm was swollen) and CHILLS (slight chills) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.  On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 04-Feb-2021, the patient experienced VACCINATION SITE SWELLING (arm was swollen) and CHILLS (slight chills). At the time of the report, VACCINATION SITE SWELLING (arm was swollen) and CHILLS (slight chills) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-035929 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: NNI
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included TAMSULOSIN for BPH.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN (body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Fatigue, Hypertension, Inappropriate affect
Clinical narrative: blood pressure was up; Feeling funny; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE AFFECT (Feeling funny), FATIGUE (Fatigue) and HYPERTENSION (blood pressure was up) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INAPPROPRIATE AFFECT (Feeling funny) and FATIGUE (Fatigue). On 01-Mar-2021, the patient experienced HYPERTENSION (blood pressure was up). On 04-Mar-2021, INAPPROPRIATE AFFECT (Feeling funny) and HYPERTENSION (blood pressure was up) had resolved. At the time of the report, FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Blood pressure measurement: (High) Unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Dizziness, Headache, Illness
Clinical narrative: very sick; dizziness; upset stomach; severe headache; chills; on a heating pad but his temperature is normal; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), DIZZINESS (dizziness), ABDOMINAL DISCOMFORT (upset stomach), HEADACHE (severe headache) and CHILLS (chills) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (The patient contracted the COVID-19 virus on 03 Jan 2021 and recovered approximately two or three weeks later) from 03-Jan-2021 to January 2021.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced ILLNESS (very sick), DIZZINESS (dizziness), ABDOMINAL DISCOMFORT (upset stomach), HEADACHE (severe headache), CHILLS (chills) and PYREXIA (on a heating pad but his temperature is normal). At the time of the report, ILLNESS (very sick), DIZZINESS (dizziness), ABDOMINAL DISCOMFORT (upset stomach), HEADACHE (severe headache), CHILLS (chills) and PYREXIA (on a heating pad but his temperature is normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: very sick; dizziness; upset stomach; severe headache; chills; on a heating pad but his temperature is normal; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), DIZZINESS (dizziness), ABDOMINAL DISCOMFORT (upset stomach), HEADACHE (severe headache) and CHILLS (chills) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (The patient contracted the COVID-19 virus on 03 Jan 2021 and recovered approximately two or three weeks later) from 03-Jan-2021 to January 2021.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced ILLNESS (very sick), DIZZINESS (dizziness), ABDOMINAL DISCOMFORT (upset stomach), HEADACHE (severe headache), CHILLS (chills) and PYREXIA (on a heating pad but his temperature is normal). At the time of the report, ILLNESS (very sick), DIZZINESS (dizziness), ABDOMINAL DISCOMFORT (upset stomach), HEADACHE (severe headache), CHILLS (chills) and PYREXIA (on a heating pad but his temperature is normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dizziness
Clinical narrative: Weakness; Dizziness; Diarrhea; This spontaneous case was reported by a non-health professional and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizziness) and DIARRHOEA (Diarrhea) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizziness) and DIARRHOEA (Diarrhea). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizziness) and DIARRHOEA (Diarrhea) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Treatment information not provided. List of concomitant medication were not given.